Best SPAC I Acquisition flags Nasdaq listing deficiency after market value falls below $35 million minimum
BSAA•Nasdaq deficiency notice and cure period
Nasdaq flagged a continued-listing deficiency tied to Best SPAC I Acquisition’s market value of listed securities.
- MVLS fell below the USD 35 million minimum for 30 consecutive business days under Nasdaq Listing Rule 5550(b)(2).
- Noncompliance also cited under Listing Rules 5550(b)(1) and 5550(b)(3).
- Nasdaq granted a 180-day cure period through Feb. 15, 2027; failure to regain compliance could trigger delisting proceedings.
- Units, Class A ordinary shares, and rights continue trading on Nasdaq under BSAAU, BSAA, and BSAAR during the compliance window.
